The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Advanced glycation end-products and the progress of diabetic vascular complications.
Open accessAbstract
Epidemiological studies have confirmed that hyperglycemia is the most important factor in the onset and progress of vascular complications, both in Type 1 and 2 diabetes mellitus. The formation of advanced glycation end-products (AGEs) correlates with glycemic control. The AGE hypothesis proposes that accelerated chemical modification of proteins by glucose during hyperglycemia contributes to the pathogenesis of diabetic complications including nephropathy, retinopathy, neuropathy and atherosclerosis. Recent studies have shown that increased formation of serum AGEs exists in diabetic children and adolescents with or without vascular complications. Furthermore, the presence of diabetic complications in children correlates with elevated serum AGEs. The level of serum AGEs could be considered as a marker of later developments of vascular complications in children with Type 1 and 2 diabetes mellitus. The careful metabolic monitoring of young diabetics together with monitoring of serum AGEs can provide useful information about impending AGE-related diabetic complications. It is becoming clear that anti-AGE strategies may play an important role in the treatment of young and older diabetic patients. Several potential drug candidates such as AGE inhibitors have been reported recently.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Biochemistry and molecular cell biology of diabetic complications
Brownlee, M. (2001) · Nature · doi:10.1038/414813a · Cited by 9,107
Amos, A. F., McCarty, D. J., & Zimmet, P. (1997) · Diabetic Medicine · doi:10.1002/(sici)1096-9136(199712)14:5+<s7::aid-dia522>3.0.co;2-r · Cited by 1,882
Radicals and oxidative stress in diabetes
West, I. C. (2000) · Diabetic Medicine · doi:10.1046/j.1464-5491.2000.00259.x · Cited by 913
Thornalley, P. J. (1990) · Biochemical Journal · doi:10.1042/bj2690001 · Cited by 816
The biology of the receptor for advanced glycation end products and its ligands
Schmidt, A. M., Yan, S. D., Yan, S. F., & Stern, D. M. (2000) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/s0167-4889(00)00087-2 · Cited by 691
The Diabetes Control and Complications Trial Research Group (1994) · Retina · doi:10.1097/00006982-199414030-00022 · Cited by 551
Glycoxidation and lipoxidation in atherogenesis
Baynes, J. W., & Thorpe, S. R. (2000) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(00)00228-8 · Cited by 514
Advanced glycation end products induce glomerular sclerosis and albuminuria in normal rats.
Vlassara, H., Striker, L. J., Teichberg, S., Fuh, H., Li, Y. M., & Steffes, M. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.24.11704 · Cited by 462
Glucose and reactive oxygen species
Bonnefont-Rousselot, D. (2002) · Current Opinion in Clinical Nutrition and Metabolic Care · doi:10.1097/00075197-200209000-00016 · Cited by 456
Kalousová, M., Škrha, J., & Zima, T. (2002) · Physiological Research · doi:10.33549/physiolres.930234 · Cited by 455
McCance, D. R., Dyer, D. G., Dunn, J. A., Bailie, K. E., Thorpe, S. R., Baynes, J. W., & Lyons, T. J. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116482 · Cited by 444
Horie, K., Miyata, T., Maeda, K., Miyata, S., Sugiyama, S., Sakai, H., van Ypersole de Strihou, C., Monnier, V. M., Witztum, J. L., & Kurokawa, K. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119853 · Cited by 433
Consequences of the diabetic status on the oxidant/antioxidant balance.
Bonnefont‐Rousselot, D., Bastard, J., Jaudon, M. C., & Delattre, J. (2000) · PubMed · Cited by 426
Advanced glycation end products increase retinal vascular endothelial growth factor expression.
Lu, M., Kuroki, M., Amano, S., Tolentino, M., Keough, K., Kim, I., Bucala, R., & Adamis, A. P. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1277 · Cited by 423
Pyridoxamine inhibits early renal disease and dyslipidemia in the streptozotocin-diabetic rat
Degenhardt, T. P., Alderson, N. L., Arrington, D. D., Beattie, R. J., Basgen, J. M., Steffes, M. W., Thorpe, S. R., & Baynes, J. W. (2002) · Kidney International · doi:10.1046/j.1523-1755.2002.00207.x · Cited by 378
The AGE Inhibitor Pyridoxamine Inhibits Development of Retinopathy in Experimental Diabetes
Stitt, A., Gardiner, T. A., Anderson, N. L., Canning, P., Frizzell, N., Duffy, N., Boyle, C., Januszewski, A. S., Chachich, M., Baynes, J. W., et al. (2002) · Diabetes · doi:10.2337/diabetes.51.9.2826 · Cited by 355
Sell, D. R., Lapolla, A., Odetti, P., Fogarty, J., & Monnier, V. M. (1992) · Diabetes · doi:10.2337/diab.41.10.1286 · Cited by 310
Chelating Activity of Advanced Glycation End-product Inhibitors
Price, D. L., Rhett, P. M., Thorpe, S. R., & Baynes, J. W. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m108196200 · Cited by 308
The AGE‐receptor in the pathogenesis of diabetic complications
Vlassara, H. (2001) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.233 · Cited by 301
Miyata, T., van Ypersele de Strihou, C., Ueda, Y., Ichimori, K., Inagi, R., Onogi, H., Ishikawa, N., Nangaku, M., & Kurokawa, K. (2002) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000032418.67267.f2 · Cited by 290
Amadorins: Novel Post-Amadori Inhibitors of Advanced Glycation Reactions
Khalifah, R. G., Baynes, J. W., & Hudson, B. G. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.0371 · Cited by 268
Onorato, J. M., Jenkins, A. J., Thorpe, S. R., & Baynes, J. W. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m003263200 · Cited by 250
Niwa, T., Katsuzaki, T., Miyazaki, S., Miyazaki, T., Ishizaki, Y., Hayase, F., Tatemichi, N., & Takei, Y. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119285 · Cited by 196
Miura, J., Yamagishi, S., Uchigata, Y., Takeuchi, M., Yamamoto, H., Makita, Z., & Iwamoto, Y. (2002) · Journal of Diabetes and its Complications · doi:10.1016/s1056-8727(02)00183-6 · Cited by 157
Vascular targets of redox signalling in diabetes mellitus
Spitaler, M. M., & Graier, W. F. (2002) · Diabetologia · doi:10.1007/s00125-002-0782-0 · Cited by 152
The role of free radicals, oxidative stress and antioxidant systems in diabetic vascular disease
Jakuš, V. (2000) · Bratislavské lekárske listy/Bratislava medical journal · doi:10.1007/bf03656352 · Cited by 149
Self-citationLyons, T. J., & Jenkins, A. J. (1997) · PubMed · Cited by 148
Šebeková, K., Kupčová, V., Schinzel, R., & Heidland, A. (2002) · Journal of Hepatology · doi:10.1016/s0168-8278(01)00232-x · Cited by 130
Berg, T. J., Bangstad, H. ‐., Torjesen, P. A., Østerby, R., Bucala, R., & Hanssen, K. F. (1997) · Metabolism · doi:10.1016/s0026-0495(97)90010-x · Cited by 124
Chen, S., Cohen, M. P., Lautenslager, G. T., Shearman, C. W., & Ziyadeh, F. N. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.059002673.x · Cited by 113
Long-term assessment of glucose control by haemoglobin-AGE measurement
Wolffenbuttel, B. H. R., Giordano, D., Founds, H., & Bucala, R. (1996) · The Lancet · doi:10.1016/s0140-6736(96)91141-1 · Cited by 104
Cooper, M. E., Thallas, V., Forbes, J. M., Scalbert, E., Sastra, S. A., Darby, I. A., & Soulis, T. (2000) · Diabetologia · doi:10.1007/s001250051355 · Cited by 102
Soulis, T., Cooper, M. E., Sastra, S. A., Thallas, V., Panagiotopoulos, S., Bjerrum, O. J., & Jerums, G. (1997) · Diabetologia · doi:10.1007/s001250050799 · Cited by 101
Exercise, free radicals, and lipid peroxidation in type 1 diabetes mellitus
Davison, G. W., George, L., Jackson, S. K., Young, I. S., Davies, B., Bailey, D. M., Peters, J. R., & Ashton, T. (2002) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(02)01090-0 · Cited by 95
Parameters of oxidative stress in children with Type 1 diabetes mellitus and their relatives
Varvařovská, J., Ráček, J., Stožický, F., Souček, J., Trefil, L., & Pomahačová, R. (2002) · Journal of Diabetes and its Complications · doi:10.1016/s1056-8727(01)00228-8 · Cited by 75
Takeuchi, M., & Makita, Z. (2001) · Current Molecular Medicine · doi:10.2174/1566524013363735 · Cited by 71
Berg, T. J., Dahl‐Jørgensen, K., Torjesen, P. A., & Hanssen, K. F. (1997) · Diabetes Care · doi:10.2337/diacare.20.6.1006 · Cited by 66
Advanced glycation end products in children with chronic renal failure and type 1 diabetes
Misselwitz, J., Franke, S., Kauf, E., John, U., & Stein, G. (2002) · Pediatric Nephrology · doi:10.1007/s00467-001-0815-9 · Cited by 47
Turk, Z., Mesić, R., & Benko, B. (1998) · Clinica Chimica Acta · doi:10.1016/s0009-8981(98)00128-4 · Cited by 46
Plasma levels of advanced glycation end products in children with renal disease
ebekov�, K., Podrack�, Bla?�?ek, P., Syrov�, D., Heidland, A., & Schinzel, R. (2001) · Pediatric Nephrology · doi:10.1007/s004670100038 · Cited by 45
Miyoshi, H., Taguchi, T., SUGIURA, M., Takeuchi, M., Yanagisawa, K., Watanabe, Y., Miwa, I., Makita, Z., & Koike, T. (2002) · Hormone and Metabolic Research · doi:10.1055/s-2002-33478 · Cited by 43
Koga, K., Yamagishi, S., Okamoto, T., Inagaki, Y., Amano, S., Takeuchi, M., & Makita, Z. (2002) · PubMed · Cited by 39
Miyata, T. (2002) · PubMed · Cited by 22
Jakuš, V., Bauerová, K., Michalková, D., & Čársky, J. (2000) · Bratislavské lekárske listy/Bratislava medical journal · doi:10.1007/bf03656343 · Cited by 15
Self-citation
Cited by
Role of advanced glycation end products in cellular signaling
Ott, C., Jacobs, K., Haucke, E., Navarrete Santos, A., Grune, T., & Simm, A. (2014) · Redox Biology · doi:10.1016/j.redox.2013.12.016 · Cited by 1,150
“…. . . . . . . . . . . 414 Receptor for AGEs (RAGE). . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 414 The AGE-receptor complex (AGE-R) . . . . . . . . . . . .…”
Microvasular and macrovascular complications in diabetes mellitus: Distinct or continuum?
Chawla, R., Chawla, A., & Jaggi, S. (2016) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/2230-8210.183480 · Cited by 1,106
Advanced Glycation End Products and Diabetes Mellitus: Mechanisms and Perspectives
Khalid, M., Petroianu, G., & Adem, A. (2022) · Biomolecules · doi:10.3390/biom12040542 · Cited by 879
A Glimpse of Various Pathogenetic Mechanisms of Diabetic Nephropathy
Kanwar, Y. S., Sun, L., Xie, P., Liu, F.-Y., & Chen, S. (2011) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev.pathol.4.110807.092150 · Cited by 775
Diabetic Nephropathy: Mechanisms of Renal Disease Progression
Kanwar, Y. S., Wada, J., Sun, L., Xie, P., Wallner, E. I., Chen, S., Chugh, S., & Danesh, F. R. (2008) · Experimental Biology and Medicine · doi:10.3181/0705-mr-134 · Cited by 596
Metadata
- Authors
- Jakuš, V, & Rietbrock, N.
- Venue
- Physiological Research
- Published
- 2004
- Volume
- 53
- Issue
- 2
- Pages
- 131-142
- ISSN
- 0862-8408 (ISSN-L)
- 1802-9973
- OpenAlex
- W147553750
- Cited by
- 341
- References
- 45
- FWCI
- 9.84
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.